Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data demonstrating how the Viz HCM module enables faster, accurate detection of signs of hypertrophic cardiomyopathy (HCM) to help ensure that more patients receive the care they need.

DELRAY BEACH, Fla., Dec. 19, 2024 /PRNewswire/ -- The global artificial intelligence in healthcare market, valued at US$10.31 billion in 2023, is forecasted to grow at a robust CAGR of 49.1%, reaching US$14.92 billion in 2024 and an impressive US$164.16 billion by 2030. The market growth is primarily driven by the increase in the chronic diseases such as heart disease, stroke, diabetes, and cancer subsequently putting significant pressure on healthcare service providers to optimize their operations. Moreover, technological advancements in machine learning algorithms, cloud computing, data analytics, and other sophisticated technologies is largely driving the market growth. Companies are updating their product portfolio to incorporate artificial intelligence into their offerings. For instance, GE Healthcare, Cognizant, and many more have upgraded their Artificial Intelligence (AI) in healthcare capabilities to enhance overall healthcare experience